Ra Pharmaceuticals to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 6, 2018--Ra Pharmaceuticals, Inc. (NASDAQ:RARX) today announced that senior management will present at the following upcoming investor conferences:The Credit Suisse 27th Annual Healthcare Conference on Tuesday, November 13, 2018 at 4:35 p.m. M.T. The conference is being held at the Phoenician Resort in Scottsdale, AZ. The Stifel 2018 Healthcare Conference on November 13, 2018 at 3:30 p.m. E.T. The conference is being held at the Lotte New York Palace Hotel. The Jefferies Global Healthcare Conference on Thursday, November 15, 2018 at 2:40 p.m. GMT.
The presentations will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentations will also be available and archived on the site for three weeks following each presentation.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181106005164/en/
CONTACT: Argot Partners
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL
SOURCE: Ra Pharmaceuticals, Inc.
Copyright Business Wire 2018.
PUB: 11/06/2018 07:30 AM/DISC: 11/06/2018 07:30 AM